FHPI HCL
- CAS No.
- 350228-36-3
- Chemical Name:
- FHPI HCL
- Synonyms
- FHPI HCL;SB202190 HCL;SB 202190, HYDROCHLORIDE;SB 202190 monohydrochloride hydrate;SB 202190, Hydrochloride - CAS 350228-36-3 - Calbiochem;4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)-1H-IMIDAZOLE HCL;4-(4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1h-imidazol-2-yl)phenol hydrochloride;4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-iMidazol-2-yl]phenol Monohydrochloride;4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)-1H-IMIDAZOLE HYDROCHLORIDE;4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol monohydrochloride hydrate
- CBNumber:
- CB6321057
- Molecular Formula:
- C20H15ClFN3O
- Molecular Weight:
- 367.8
- MDL Number:
- MFCD01862621
- MOL File:
- Mol file
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H315-H319-H335 | |||||||||
| Precautionary statements | P261-P305+P351+P338 | |||||||||
| Hazard Codes | Xi | |||||||||
| Risk Statements | 36/37/38 | |||||||||
| Safety Statements | 26-36/37 | |||||||||
| WGK Germany | 3 | |||||||||
| NFPA 704 |
|
FHPI HCL price More Price(13)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | S7076 | SB 202190 monohydrochloride hydrate ≥98% (HPLC) | 350228-36-3 | 5mg | $134 | 2024-03-01 | Buy |
| Cayman Chemical | 21201 | SB 202190 (hydrochloride) ≥98% | 350228-36-3 | 1mg | $32 | 2024-03-01 | Buy |
| Cayman Chemical | 21201 | SB 202190 (hydrochloride) ≥98% | 350228-36-3 | 5mg | $86 | 2024-03-01 | Buy |
| Sigma-Aldrich | S7076 | SB 202190 monohydrochloride hydrate ≥98% (HPLC) | 350228-36-3 | 25mg | $545 | 2024-03-01 | Buy |
| Cayman Chemical | 21201 | SB 202190 (hydrochloride) ≥98% | 350228-36-3 | 10mg | $122 | 2024-03-01 | Buy |
FHPI HCL Chemical Properties,Uses,Production
Uses
The water soluble form of SB 202190, a highly selective, potent inhibitor of p38 MAP kinase. SB-202190 is able to promote proliferation of C6 cells in lower concentration but induced apoptosis in higher levels. Studies show that SB202190 can protect neural function from ischemia/reperfusion injury and regulate the activation of Bcl-2 and Bax protein after ischemia/reperfusion in rat.
Uses
The water soluble form of SB 202190, a highly selective, potent inhibitor of p38 MAP kinase. SB-202190 is able to promote proliferation of C6 cells in lower concentration but induced apoptosis in high er levels. Studies show that SB202190 can protect neural function from ischemia/reperfusion injury and regulate the activation of Bcl-2 and Bax protein after ischemia/reperfusion in rat.
General Description
A water-soluble form of the potent p38 MAP kinase inhibitor SB 202190 (Cat. No. 559388).
Biochem/physiol Actions
SB 202190 monohydrochloride hydrate mediates the phosphorylation of serine in the mutant p53 protein and modulates cell adhesion and prevents cell proliferation in breast cancer cell lines.
FHPI HCL Preparation Products And Raw materials
Raw materials
Preparation Products
FHPI HCL Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49739 | 58 |
| Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 52927 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131981 | 58 |
| J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 | jkinfo@jkchemical.com | China | 94838 | 76 |
| Chemsky (shanghai) International Co.,Ltd | 021-50135380 | shchemsky@sina.com | China | 15421 | 60 |
| NCE Biomedical Co.,Ltd. | 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 | China | 1494 | 55 | |
| SYN|thesis med chem P/L | +86-021-50720296 | service@synkinase.com | China | 266 | 58 |
| Sigma-Aldrich | 021-61415566 800-8193336 | orderCN@merckgroup.com | China | 51471 | 80 |
| SPIRO PHARMA | eric_feng1954@126.com | China | 9254 | 55 | |
| Pharmacodia (Beijing) Co.,Ltd | +86-400-851-9921 | sales@pharmacodia.com | China | 2317 | 55 |